Biosynex SA (EPA:ALBIO)

Biosynex Revenue

In the year 2025, Biosynex had annual revenue of 95.19M EUR, down -5.90%. Biosynex had revenue of 44.67M in the half year ending December 31, 2025, with 64.19% growth.

• Revenue: 95.19M
• Revenue Growth: -5.90%
• P/S Ratio: 0.18
• Revenue / Employee: 239.78K
• Employees: 397
• Market Cap: 16.66M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	95.19M	-5.97M	-5.90%
Dec 31, 2024	101.17M	31.31M	44.82%
Dec 31, 2023	69.86M	-68.74M	-49.60%
Dec 31, 2022	138.60M	-98.70M	-41.59%
Dec 31, 2021	237.30M	83.41M	54.20%
Dec 31, 2020	153.90M	118.72M	337.54%
Dec 31, 2019	35.17M	3.96M	12.69%
Dec 31, 2018	31.21M	668.39K	2.19%
Dec 31, 2017	30.54M	3.51M	12.97%
Dec 31, 2016	27.04M	6.90M	34.30%
Dec 31, 2015	20.13M	16.06M	394.24%
Dec 31, 2014	4.07M	2.25M	123.55%
Dec 31, 2013	1.82M	289.31K	18.88%
Dec 31, 2012	1.53M	482.16K	45.90%
Dec 31, 2011	1.05M	43.43K	4.31%
Dec 31, 2010	1.01M	318.20K	46.19%
Dec 31, 2009	688.88K	203.45K	41.91%
Dec 31, 2008	485.43K	262.25K	117.51%
Dec 31, 2007	223.18K	105.09K	88.99%
Dec 31, 2006	118.09K	-	-

Data Source: Fiscal.ai Last updated: Apr 30, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 30, 2026

Data Sources Report a data error